Despite recent dramatic reductions in cot death rates in the UK, and the development of sophisticated screening for Down's syndrome, preventing stillbirth is proving tougher to tackle. Now, a major study under way at Cambridge could change all that.
Researchers at the University of Cambridge have developed a new technique which could significantly increase success rates of pregnancies and reduce the frequency of multiple pregnancies associated with in vitro fertilisation (IVF).
Cambridge researchers are pioneering a new test for autism in the womb, by measuring the levels of testosterone produced by the foetus, which makes its way into the amniotic fluid. They hope to test if children who later develop autism have unusually high levels of testosterone between 12 and 20 weeks of pregnancy.
A new method for diagnosing sickle cell disease has been found by researchers from Cambridge and Oxford Universities. This new test would be cheaper and easier to use than existing methods and provide a simpler alternative for use in developing nations.